Prevalence and clinical risk factors for esophageal candidiasis in non-human immunodeficiency virus patients: A multicenter retrospective case-control study

doi:10.4253/wjge.v15.i6.480

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3673)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

1818

Figures (1-1)

210

Tables (1-3)

192

Sum=2323

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

150

Download

475

Sum=625

Publishing Process of This Article

Item

Count

Browse

156

Download

444

Sum=600

Jun 16, 2023 (publication date) through Dec 3, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Endosc. Jun 16, 2023; 15(6): 480-490
Published online Jun 16, 2023. doi: 10.4253/wjge.v15.i6.480

Table 2 Comparison of presenting symptoms in patients with and without esophageal candidiasis, n (%)

Presenting symptom	EC¹ patients, n = 177	Matched controls, n = 247
Dysphagia	52 (16.94)	52 (11.95)
Nausea	46 (14.98)	76 (17.47)
Melena	45 (14.66)	58 (13.33)
Vomiting	42 (13.68)	79 (18.16)
Hematemesis	26 (8.47)	44 (10.11)
Epigastric pain	21 (6.84)	22 (5.06)
Weight loss	18 (5.86)	8 (1.84)
Non-specific	17 (5.54)	36 (8.28)
Abdominal pain	17 (5.54)	36 (8.28)
Diarrhea	13 (4.23)	7 (1.61)
Chest pain	12 (3.91)	18 (4.14)
Asymptomatic	11 (3.58)	11 (2.53)
Odynophagia	10 (3.26)	11 (2.53)
Dyspepsia	6 (1.95)	9 (2.07)
Acid reflux	5 (1.63)	2 (0.46)
Unknown	0 (0.00)	2 (0.46)

¹EC: Esophageal candidiasis; Unknown: presence or absence of symptoms not reported.

Citation: Kimchy AV, Ahmad AI, Tully L, Lester C, Sanghavi K, Jennings JJ. Prevalence and clinical risk factors for esophageal candidiasis in non-human immunodeficiency virus patients: A multicenter retrospective case-control study. World J Gastrointest Endosc 2023; 15(6): 480-490
URL: https://www.wjgnet.com/1948-5190/full/v15/i6/480.htm
DOI: https://dx.doi.org/10.4253/wjge.v15.i6.480